Chung K F, Cuss F M, Barnes P J
Department of Thoracic Medicine, National Heart and Lung Institute, Brompton Hospital, London, England.
Allergy Proc. 1989 Sep-Oct;10(5):333-7. doi: 10.2500/108854189778959885.
Platelet-activating factor (PAF) is a newly discovered lipid mediator of inflammation. When inhaled by normal volunteers, it induces bronchoconstriction associated with facial flushing and with a transient fall in circulating neutrophils. Of greater interest is its ability to induce prolonged increases in bronchial responsiveness to methacholine. These observations support an important role for PAF in asthama; the availability of specific PAF antagonists will allow us to test this hypothesis.
血小板活化因子(PAF)是一种新发现的炎症脂质介质。正常志愿者吸入后,它会诱发支气管收缩,并伴有面部潮红和循环中性粒细胞短暂减少。更令人感兴趣的是它能使支气管对乙酰甲胆碱的反应性长时间增强。这些观察结果支持PAF在哮喘中起重要作用;特异性PAF拮抗剂的可得性将使我们能够验证这一假说。